PUNE, India, February 3, 2016 /PRNewswire/ --
Global epigenetics market is expected to reach USD 890.0 million by 2020 growing at a CAGR of 13.64% between 2015 and 2020 with market growth majorly driven by the high prevalence of cancer, increasing R & D funding and increasing intensity of genomic research activities. Other growth factors include increasing application for non-oncology diseases and growing partnership between academic, biotechnology and pharmaceutical companies.
Complete report on global epigenetics market spread across 158 pages, profiling 10 companies and supported with 84 tables and 82 figures is now available at http://www.reportsnreports.com/reports/215227-epigenetics-technology-market-epigenomics-dna-methylation-histone-modifications-rna-interference-cancer-therapeutics-personalized-medicine-2012-2017-.html .
By product, the market includes enzymes, instruments & consumables, kits and reagents. Enzymes are further sub segmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Instruments & consumables are further sub segmented into mass spectrometers, next-generation sequencers, qPCRs, sonicators and other epigenetics instruments & consumables. Kits are further sub segmented into bisulfite conversion kits, ChIP-seq kits, RNA sequencing kits, whole genomic sequencing kits, 5-hmc and 5-mc analysis kits and other epigenetics kits. Reagents are further sub segmented into antibodies, buffers, histones, magnetic beads, primers and other epigenetics reagents. The kits segment is expected to grow at the highest rate. Based on research areas, the market is segmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.
A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global epigenetics market and its sub segments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.
The key players in the worldwide epigenetics market are Abcam plc. (U.K), Illumina, Inc. (U.S.), QIAGEN N.V. (Netherland), Merck & Co. (U.S.), New England Biolabs, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode, Inc. (Belgium) and Zymo Research Corporation (U.S.). Order a copy of Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020 research report at http://www.reportsnreports.com/purchase.aspx?name=215227 .
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). North America is further segmented into the U.S. and Canada. North America is expected to account for the largest share in the global epigenetics market in 2015. Asia is expected to register the fastest growth.
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.
On a related note, another research on Gene Expression Analysis Market Global Forecasts to 2020 says, the global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020. North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Companies like Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.) have been profiled in this 174 research report available at http://www.reportsnreports.com/reports/275022-gene-expression-analysis-market-by-technology-dna-microarray-real-time-pcr-next-generation-sequencing-consumables-dna-chips-reagents-services-gene-profiling-bioinformatics-data-analysis-software-applications-global-forecast-to-2018.html .
Explore more reports on biotechnology market at http://www.reportsnreports.com/market-research/biotechnology/ .
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Connect With Us on:
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441